Lv11
40 积分 2024-01-24 加入
Predictive value of serum high‐mobility group box 1 levels for checkpoint inhibitor pneumonitis
1小时前
已完结
Radical Minimally Invasive Surgery After Immuno-chemotherapy in Initially-unresectable Stage IIIB Non-small cell Lung Cancer
1个月前
已完结
Stepwise progression of invasive mucinous adenocarcinoma based on radiological and biological characteristics
1个月前
已完结
Shaping the tumor immune microenvironment of SCLC: Mechanisms, and opportunities for immunotherapy
2个月前
已完结
Risk of pneumonitis in non-small cell lung cancer patients with preexisting interstitial lung diseases treated with immune checkpoint inhibitors: a nationwide retrospective cohort study
8个月前
已完结
Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis
8个月前
已完结
Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trial
8个月前
已完结
Clinical Outcomes of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Non-small Cell Lung Cancer and Preexisting Interstitial Lung Diseases
8个月前
已完结
USP7 small-molecule inhibitors interfere with ubiquitin binding
8个月前
已完结
Malignant pleural effusion management: keeping the flood gates shut
8个月前
已完结
皖公网安备34019202002308
